Press Release / Sep 09, 2011
EFCG Ratifies FDA's Proposed Generic Drug User Fees Act
European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA)
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA)
Hovione’s TwinCaps® inhaler in Phase III clinical trials for influenza
Pharmaceutical Technology Sourcing and Management, July 2006
Pharmaceutical Technology Europe, February 2014
Drug Delivery Technology, April 2007